75987-080 : Krystexxa 8 mg/ml Intravenous Injection, Solution


NDC: 75987-080
Labeler: Horizon Pharma Inc.
Product Type: Human Prescription Drug
Drug Name:  Krystexxa
Dosage Form: Intravenous Injection, Solution
Application #: BLA125293
Rev. Date: 


NDC Package Codes:

  • 75987-080-10: 1 VIAL IN 1 CARTON (75987‑080‑10) > 1 ML IN 1 VIAL

Active Ingredients:

  • Pegloticase

Dosage Strength:

  • 8 mg/mL

Pharmaceutical Classes:

  • Urate Oxidase [CS]
  • Uric Acid-specific Enzyme [EPC]

Related Products:

Based on records with the same trade name.
  • 54396-801 Krystexxa 8 mg/ml Intravenous Injection, Solution by Savient Pharmaceuticals, Inc.
  • 60809-801 Krystexxa 8 mg/ml Intravenous Injection, Solution by Crealta Pharmaceuticals LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 75987-080 QR Code

< Prev: 75987-070Next: 75987-090 >

Related Discussions:

Pegloticase
sir can you send me full article of same to below mentioned email...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.